October 28, 2017
From the event website:
This lunch is your exclusive opportunity to spend up to 3 hours up close and personal with Rick Doblin, Ph.D., the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). By attending this lunch not only will you get to spend time with Rick Doblin you will also help fund the MAPS Phase 3 clinical trials of MDMA-Assisted Therapy for the treatment of PTSD. A history making study that has resulted in MDMA-Assisted Therapy being labeled a breakthrough therapy by the FDA.
Only 10 seats available
Rick received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four-year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and one of three children (two in college).
You don’t want to miss this rare opportunity to have lunch with a leader in the field of psychedelic research.
For more information, visit the event website.